CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/09/2022
Back to search
Official data from USPTO
A ABRAXIS BIOSCIENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
65
Latest update
12/09/2022
Classification
Registered
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
04/19/2006
Registration date
01/12/2010
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/01/2019
Last transaction
12/09/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2006-00-00
First use in commerce
2008-03-00
Drawing code
3
Owner type
16
Owner location
Summit, NJ, US
Examiner
GAST, PAUL
Law office
L60
Current location
TMEG LAW OFFICE 106
Mark description
The mark consists in part of a stylized letter "A".
Holders and representatives
Holders
ABRAXIS BIOSCIENCE, LLC
ABRAXIS BIOSCIENCE, LLC
Abraxis BioScience, Inc.
Representatives
Marilyn F. Kelly Bristol-Myers Squibb Company
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalsoncolytics; pharmaceuticals for the treatment of cancer; pharmaceuticals to treat vascular diseases; drug delivery system composed of nanoparticles sold as an integral component of drugs
Class 42
research and development in the field of pharmaceuticals and drug delivery; technical consultation in the field of pharmaceuticals for the treatment of cancer and nanoparticles employed for drug delivery or as diagnostic agents
Class 44
medical information services; medical consultation in the field of pharmaceuticals for the treatment of cancernanoparticles employed for drug delivery or as diagnostic agents
Publications
History of USPTO decisions and trademark events.
65 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/09/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/09/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/09/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/09/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/09/2022
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/01/2019
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/01/2019
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
07/01/2019
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
07/01/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/01/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
05/23/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/12/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/25/2016
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/25/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/27/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/28/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/28/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/28/2015
E815
TEAS SECTION 8 & 15 RECEIVED
01/14/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/15/2010
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/15/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
01/12/2010
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
12/04/2009
ALIE
ASSIGNED TO LIE
12/04/2009
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/18/2009
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/13/2009
IUAF
USE AMENDMENT FILED
11/11/2009
EISU
TEAS STATEMENT OF USE RECEIVED
11/11/2009
EX5G
SOU EXTENSION 5 GRANTED
06/26/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/26/2009
EXT5
SOU EXTENSION 5 FILED
06/04/2009
EEXT
SOU TEAS EXTENSION RECEIVED
06/04/2009
EX4G
SOU EXTENSION 4 GRANTED
10/28/2008
EXT4
SOU EXTENSION 4 FILED
10/28/2008
EEXT
SOU TEAS EXTENSION RECEIVED
10/28/2008
EX3G
SOU EXTENSION 3 GRANTED
05/22/2008
EXT3
SOU EXTENSION 3 FILED
05/15/2008
EEXT
SOU TEAS EXTENSION RECEIVED
05/15/2008
EX2G
SOU EXTENSION 2 GRANTED
12/13/2007
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/05/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/29/2007
EXT2
SOU EXTENSION 2 FILED
11/27/2007
EEXT
SOU TEAS EXTENSION RECEIVED
11/27/2007
EX1G
SOU EXTENSION 1 GRANTED
05/16/2007
EXT1
SOU EXTENSION 1 FILED
05/16/2007
EEXT
SOU TEAS EXTENSION RECEIVED
05/16/2007
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/07/2007
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/07/2007
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
12/05/2006
PUBO
PUBLISHED FOR OPPOSITION
09/12/2006
NPUB
NOTICE OF PUBLICATION
08/23/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/25/2006
ALIE
ASSIGNED TO LIE
07/25/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/26/2006
ACEC
AMENDMENT FROM APPLICANT ENTERED
06/26/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/23/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/23/2006
CEPE
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
06/21/2006
ALIE
ASSIGNED TO LIE
06/20/2006
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
06/19/2006
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
06/19/2006
DOCK
ASSIGNED TO EXAMINER
06/13/2006
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
04/27/2006
NWAP
NEW APPLICATION ENTERED
04/26/2006
Continuous trademark protection
Get notified about every new filing that threatens A ABRAXIS BIOSCIENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.